Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unrelated Cord Blood Transplantation in Poor Risk Haematological Malignancies
NCT00916045Phase 2Terminated
- Sponsor
- King's College Hospital
- Start
- Sep 2009
- Primary completion
- Mar 2012
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by King's College Hospital. Started Sep 2009; status: terminated.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)acute lymphoblastic leukemia (ALL)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00916045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916045.